Program seeks Council approval for the initiative titled, NICHD Domestic & International Pediatric & Maternal HIV & Other High-Priority Infectious Diseases Clinical Studies Network. The Maternal and Pediatric Infectious Disease Branch (MPIDB) develops, implements, and directs a wide range of domestic and international research activities for the study of the pathogenesis, epidemiology, cure, risk factors and co-factors for HIV and related co-infections in pregnant person, infants, children, and adolescents. The evaluation of new and improved therapies for treatment of HIV, and its associated complications in children and pregnant person and further reduction of perinatal transmission, including a potential cure, is a high priority for the NICHD. Because of the unique aspects of HIV in children, pregnant persons, and adolescents, a pediatric/perinatal-and adolescent specific clinical trials system with clinical trials sites to expediently evaluate therapeutic agents in children and pregnant persons living with HIV is essential. The sites and infrastructure supported by this initiative will also engage in collaborations and studies with other HIV and relevant clinical trials networks, ensuring the inclusion of pediatric and maternal populations. This initiative will continue providing essential support for critical infrastructure to enhance maternal, pediatric, and adolescent therapeutic and prevention research not only in HIV, but other high-priority infectious diseases as well.
This proposed concept aligns with the NICHD Strategic Plan Themes 2, 3, 4, and 5, as well as Cross-Cutting areas of disease prevention, infectious disease, global health and health disparities.
This proposed concept aligns with the NICHD MPIDB research priorities in HIV and Emerging/Re-Emerging Infectious Diseases, as well as the Office of AIDS Research HIV/AIDS priorities.
Maternal & Pediatric Infectious Disease Branch (MPIDB)
Back to Concept Review by Council